Integer (ITGR) Competitors

$117.68
+5.67 (+5.06%)
(As of 05/15/2024 ET)

ITGR vs. MASI, LIVN, TMDX, CNMD, SLNO, INMD, CRNX, PACS, SMMT, and INSM

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Masimo (MASI), LivaNova (LIVN), TransMedics Group (TMDX), CONMED (CNMD), Soleno Therapeutics (SLNO), InMode (INMD), Crinetics Pharmaceuticals (CRNX), PACS Group (PACS), Summit Therapeutics (SMMT), and Insmed (INSM). These companies are all part of the "medical" sector.

Integer vs.

Masimo (NASDAQ:MASI) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Masimo presently has a consensus price target of $138.71, indicating a potential upside of 20.54%. Integer has a consensus price target of $128.67, indicating a potential upside of 10.24%. Given Integer's higher possible upside, research analysts clearly believe Masimo is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Masimo
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Integer
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Masimo received 76 more outperform votes than Integer when rated by MarketBeat users. Likewise, 63.84% of users gave Masimo an outperform vote while only 63.51% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
MasimoOutperform Votes
452
63.84%
Underperform Votes
256
36.16%
IntegerOutperform Votes
376
63.51%
Underperform Votes
216
36.49%

Integer has lower revenue, but higher earnings than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Masimo$2.05B3.04$81.50M$1.4779.67
Integer$1.60B2.46$90.65M$2.8940.54

In the previous week, Masimo and Masimo both had 26 articles in the media. Masimo's average media sentiment score of 0.48 beat Integer's score of 0.37 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Masimo
8 Very Positive mention(s)
2 Positive mention(s)
12 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Integer
8 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

86.0% of Masimo shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 9.7% of Masimo shares are owned by insiders. Comparatively, 2.0% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Integer has a net margin of 6.01% compared to Integer's net margin of 4.01%. Integer's return on equity of 13.26% beat Masimo's return on equity.

Company Net Margins Return on Equity Return on Assets
Masimo4.01% 13.26% 5.87%
Integer 6.01%11.25%5.69%

Masimo has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.

Summary

Masimo beats Integer on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$3.92B$3.22B$5.08B$18.01B
Dividend YieldN/A1.67%36.92%3.46%
P/E Ratio40.547.72139.9323.20
Price / Sales2.4665.862,314.2310.66
Price / Cash14.1967.2835.5619.63
Price / Book2.574.185.496.08
Net Income$90.65M$86.25M$104.35M$965.90M
7 Day Performance3.54%3.06%1.27%2.26%
1 Month Performance-1.34%-0.91%2.74%5.67%
1 Year Performance47.82%4.25%6.12%131.87%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MASI
Masimo
4.6413 of 5 stars
$136.00
-1.4%
$137.43
+1.1%
-33.2%$7.20B$2.05B90.075,200High Trading Volume
LIVN
LivaNova
1.6561 of 5 stars
$63.12
+0.8%
$66.20
+4.9%
+30.5%$3.42B$1.15B-105.202,900Short Interest ↓
Positive News
TMDX
TransMedics Group
2.6333 of 5 stars
$127.28
-4.0%
$119.00
-6.5%
+75.0%$4.19B$241.62M-374.35584Insider Selling
Short Interest ↓
CNMD
CONMED
4.9952 of 5 stars
$71.65
+1.3%
$107.86
+50.5%
-39.8%$2.21B$1.24B27.454,000Short Interest ↓
Positive News
Gap Up
SLNO
Soleno Therapeutics
4.1858 of 5 stars
$46.80
+1.9%
$55.60
+18.8%
+948.2%$1.56BN/A-15.7633Analyst Forecast
Gap Up
INMD
InMode
2.5678 of 5 stars
$18.50
-0.8%
$32.80
+77.3%
-44.7%$1.55B$492.05M8.77581Short Interest ↑
CRNX
Crinetics Pharmaceuticals
3.8272 of 5 stars
$47.66
+2.5%
$54.00
+13.3%
+122.5%$3.75B$4.01M-12.88290Earnings Report
Analyst Forecast
Insider Selling
Short Interest ↓
News Coverage
PACS
PACS Group
1.9205 of 5 stars
$24.99
+0.2%
$30.50
+22.0%
N/A$3.75BN/A0.0032,433Analyst Forecast
SMMT
Summit Therapeutics
1.3317 of 5 stars
$5.31
+18.8%
$8.00
+50.7%
+172.4%$3.73B$700,000.00-33.19105Gap Up
High Trading Volume
INSM
Insmed
4.5255 of 5 stars
$26.08
+0.5%
$44.92
+72.2%
+35.9%$3.87B$305.21M-4.88373Earnings Report
Analyst Forecast
Insider Selling
Short Interest ↓
News Coverage

Related Companies and Tools

This page (NYSE:ITGR) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners